Open AccessLipid accumulation product better predicts metabolic status in lean polycystic ovary syndrome than that by visceral adiposity index
Author(s) -
Hurjahan Banu,
Md Shahed Morshed,
Tania Sultana,
Sukanti Shah,
Shazia Afrine,
Muhammad Abul Hasanat
Publication year - 2022
Publication title -
journal of human reproductive sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 31
eISSN - 0974-1208
pISSN - 1998-4766
DOI - 10.4103/jhrs.jhrs_114_21
Subject(s) - polycystic ovary , medicine , insulin resistance , endocrinology , waist , body mass index , quantitative insulin sensitivity check index , triglyceride , metabolic syndrome , diabetes mellitus , insulin , cholesterol , insulin sensitivity
Both visceral adiposity index (VAI) and lipid accumulation product (LAP) can be used to assess insulin resistance (IR) and metabolic syndrome (MetS) which are required for management of even lean polycystic ovary syndrome (PCOS) (body mass index [BMI] <23 kg/m 2 ).